As many Americans and others around the globe prepare for holiday travel and get-togethers, the omicron variant continues to be a concern. While the available data on transmission, vaccine effectiveness and severity of disease are still preliminary, here’s what we’ve learned so far.
Stories by Lori Robertson
Researchers Studying Whether Mouthwashes Can Reduce Viral Load, COVID-19 Transmission
In a Dec. 8 town hall meeting, Sen. Ron Johnson may have left a misleading impression in saying “standard gargle, mouthwash, has been proven to kill the coronavirus.” In the laboratory, some mouthwashes have been shown to block infectivity or suppress SARS-CoV-2, but studies involving people using mouthwash are not conclusive. Researchers are continuing to study the matter.
Q&A on the Omicron Variant
On Nov. 24, South Africa told the World Health Organization that amid a recent increase in COVID-19 cases, it had identified a new variant — later named omicron — with a high number of mutations, raising concerns that it could spread more easily than other variants of the coronavirus. We’ll go through what we know so far about omicron.
Benefits Outweigh Risks of Pediatric COVID-19 Vaccine, Contrary to Posts Misusing VAERS Data
CBO: Build Back Better Not Quite ‘Fully Paid For’
White House Uses ‘Job-Years,’ Not Jobs, to Tout Infrastructure Law
Aaron Rodgers’ Inaccurate COVID-19 Claims
Why It’s Easy to Misinterpret Numbers of Deaths Among the Vaccinated
Raw numbers of hospitalizations or deaths among those who are vaccinated are not a good indicator of whether vaccines are effective. If the large majority of a population is vaccinated, it’s not surprising if most deaths are among the vaccinated. But social media posts misuse data from the U.K. to suggest the COVID-19 vaccines don’t work.